netFormulary NHS
Herefordshire & Worcestershire
Medicines and Prescribing Committee
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
02.03.02  Expand sub section  Drugs for arrhythmias
02.03.02  Expand sub section  Supraventricular arrhythmias
Adenosine
View adult BNF View SPC online View childrens BNF 		Formulary
Red 		 
 
Dronedarone
View adult BNF View SPC online View childrens BNF 		Restricted Drug Restricted
Amber

Only following specialist initiation and in line with NHSE&I "Items which should not routinely be prescribed in primary care" and NICE TA197.


See also HWCCG Dronedarone Prescribing Guidelines and MHRA guidance on cardiovascular, hepatic and pulmonary toxicity.

 
Link  HW CCG Dronedarone Prescribing Guidelines
Link  MHRA Drug safety update Dronedarone (Multaq): cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring requirements October 2014
Link  NHSE/I: Items which should not routinely be prescribed in primary care: Guidance for CCGs
Link  NICE TA 197 Dronedarone for the treatment of non-permanent atrial fibrilation (Update Dec 2012)
 
02.03.02  Expand sub section  Supraventricular and ventricular arrhythmias
02.03.02  Expand sub section  Ventricular arrhythmias
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Red

 Secondary care only, not to be prescribed in primary care.   

Amber 2

 Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline   

Amber with Shared Care

 Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline   

Amber

 Considered suitable for primary care prescribing following specialist initiation/recommendation.  

Green

 Considered appropriate for prescribing in both secondary and primary care. Suitable for initiation in primary care.   

netFormulary